Enter assignee name

% Expired Patents = 20.8

Forward Citations = 829

Loading Chart...

6 inventors (with patents filed for the assignee):

Pankaj Modi (20 out of 36 patents)

Ming Li (4 out of 15 patents)

Zhen Zhou (1 out of 45 patents)

4. Lei Cheng (1 out of 3 patents)

5. Xiaoli Lin (1 out of 1 patent)

6. Zhongyu Li (1 out of 1 patent)

24 patents: Sort by Forward Citations

1. 9950019 - Compositions and methods for the prevention and treatment of brain diseases and conditions (2018-04-24),

2. 9629884 - Compositions and methods for increasing lifespan and health span (2017-04-25),

3. 9283255 - Compositions and methods for the prevention and treatment of red blood cell coagulation (2016-03-15),

4. 9050277 - [object Object] (2015-06-09),

5. 7687453 - Method for administering insulin to the buccal region (2010-03-30),

6. 7255102 - Metered dose spray device for use with macromolecular pharmaceutical agents such as insulin (2007-08-14),

7. 7087215 - Methods of administering and enhancing absorption of pharmaceutical agents (2006-08-08),

8. 7070799 - Method for administering insulin to the buccal region (2006-07-04),

9. 6979668 - Cleaning compound for and method of cleaning valves and actuators of metered dose dispensers containing pharmaceutical compositions (2005-12-27),

10. 6451286 - Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds (2002-09-17),

11. 6436367 - Aerosol formulations for buccal and pulmonary application (2002-08-20),

12. 6432383 - Method for administering insulin (2002-08-13),

13. 6375975 - Pharmaceutical compositions for buccal and pulmonary application (2002-04-23),

14. 6350458 - Mixed micellar drug deliver system and method of preparation (2002-02-26),

15. 6350432 - Pressurized container having an aerosolized pharmaceutical composition (2002-02-26),

Generex Pharmaceuticals, Inc. is a biopharmaceutical company based in Toronto, Canada, specializing in the development of innovative drug delivery systems and therapeutic solutions. The company focuses on advancing treatments for various medical conditions, particularly in the fields of oncology and metabolic diseases. Generex is dedicated to enhancing patient outcomes through its proprietary technologies, which aim to improve the efficacy and safety of existing therapies while also exploring new avenues for drug development.

Profile summary based on public USPTO records.